Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

• Status: Recruiting
• Trial end date: 2027-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Collaborators: Calydial; Centre de dialyse d'Alès; Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat; Centre hospitalier de Chambéry; Centre hospitalier de Perpignan; CH du Puy en Velay, Hôpital Emile Roux; CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex; Hôpital Edouard Herriot; Hôpital Lapeyronie; Ministry of Health, France; Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex; University Hospital of Saint-Etienne; University Hospital, Toulouse
• Treatments: Enoxaparin; Ethanol

Criteria

Inclusion Criteria:

• end-stage renal disease

• chronic hemodialysis/hemodiafiltration at least three times a week

• functional TC inserted for at least two weeks

• Social security cover

• Written informed consent

Exclusion Criteria:

-